Palisade Capital Management »

Heron Therapeutics shares owned by Palisade Capital Management

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Palisade Capital Management from 13F filings

Historical chart of Palisade Capital Management investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Palisade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Palisade Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.2M 3.6M 1.70
2023-09-30 $4.2M 4.1M 1.03
2023-06-30 $4.8M 4.1M 1.16
2023-03-31 $6.0M 4.0M 1.51
2022-12-31 $9.5M 3.8M 2.50
2022-09-30 $14M 3.4M 4.22
2022-06-30 $8.3M 3.0M 2.79
2022-03-31 $17M 2.9M 5.72
2021-12-31 $28M 3.0M 9.13
2021-09-30 $27M 2.5M 10.69
2021-06-30 $28M 1.8M 15.52
2021-03-31 $17M 1.1M 16.21
2020-12-31 $19M 891k 21.17
2020-09-30 $12M 821k 14.82
2020-06-30 $9.9M 675k 14.71
2020-03-31 $7.9M 670k 11.74
2019-12-31 $14M 595k 23.50
2019-09-30 $10M 541k 18.50
2019-06-30 $9.4M 507k 18.59
2019-03-31 $9.4M 385k 24.44
2018-12-31 $7.9M 304k 25.94